Nykredit A S Purchases Shares of 28,001 The Clorox Company $CLX

Key Points

• Nykredit A/S acquired 28,001 Clorox shares in the second quarter, valued at approximately $2.67 million. Institutional investors collectively own 78.53% of the company.
• Clorox reported quarterly earnings of $1.66 per share, slightly above estimates, while revenue reached $1.95 billion but declined 2% year over year. The stock recently traded at $87.11, near its 12-month low.
• Clorox increased its quarterly dividend to $1.25, implying an annualized yield of about 5.7%, though its payout ratio is above 100%. Analysts remain cautious, with a consensus “Reduce” rating and an average price target of $101.40.

Nykredit A S acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 28,001 shares of the company's stock, valued at approximately $2,672,000.

Other large investors also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Clorox in the second quarter valued at approximately $958,640,000. Geode Capital Management LLC raised its holdings in Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company's stock worth $318,613,000 after purchasing an additional 10,060 shares during the last quarter. Van ECK Associates Corp lifted its holdings in shares of Clorox by 15.7% in the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company's stock valued at $316,244,000 after purchasing an additional 426,433 shares in the last quarter. Bank of America Corp DE purchased a new stake in shares of Clorox in the second quarter valued at $179,780,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Clorox by 9.6% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,619,396 shares of the company's stock valued at $163,284,000 after buying an additional 142,463 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Trading Up 2.6%

NYSE:CLX opened at $87.11 on Wednesday. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80. The company's 50 day moving average is $97.92 and its 200-day moving average is $98.46. The firm has a market cap of $10.53 billion, a price-to-earnings ratio of 18.07, a P/E/G ratio of 2.66 and a beta of 0.56. The Clorox Company has a 12 month low of $82.51 and a 12 month high of $128.90.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the prior year, the company earned $2.87 EPS. The firm's revenue for the quarter was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Equities analysts anticipate that The Clorox Company will post 5.8 EPS for the current year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th were paid a $1.25 dividend. The ex-dividend date was Wednesday, August 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.7%. This is a positive change from Clorox's previous quarterly dividend of $1.24. Clorox's dividend payout ratio is currently 103.73%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CLX shares. Wells Fargo & Company decreased their price target on shares of Clorox from $102.00 to $90.00 and set an "equal weight" rating on the stock in a report on Friday, September 11th. Wall Street Zen upgraded Clorox from a "sell" rating to a "hold" rating in a research note on Saturday. BNP Paribas Exane reduced their price objective on Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research report on Monday, July 20th. JPMorgan Chase & Co. increased their price target on Clorox from $92.00 to $95.00 and gave the company an "underweight" rating in a research note on Tuesday, August 4th. Finally, UBS Group restated a "neutral" rating on shares of Clorox in a report on Friday, September 11th. Thirteen equities research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Reduce" and a consensus target price of $101.40.

Clorox Company Profile

The Clorox Company NYSE: CLX is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.

Clorox's brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt's Bees, Hidden Valley, and products marketed under the Glad name.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.